( Colen et al., 2014 ) showed that biomarker signatures can be used to identify distinct GBM phenotypes associated with highly significant differences in survival and specific molecular pathways.
← all excerpts
DEMARCATE: Density-based magnetic resonance image clustering for assessing tumor heterogeneity in cancer.
1
—
—